戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 r to that of other (11)C-labeled ligands for neuroreceptors.
2  to image and measure radioligand binding to neuroreceptors.
3  in the maturation of multi-subunit Cys-loop neuroreceptors.
4  have demonstrated widespread structural and neuroreceptor abnormalities beyond the region of MCD tha
5 PET/fMRI enables characterization of dynamic neuroreceptor adaptations in vivo, and may offer a first
6 own to modulate the activity of a variety of neuroreceptors and ion channels.
7 discovery efforts targeting ion channels and neuroreceptors and mechanistic insights for the complex
8 luminating subtle structural distinctions in neuroreceptors and related integral membrane proteins.
9  2, a dimeric, multidomain G protein-coupled neuroreceptor, and describe a previously unknown conform
10  activated by an immunoreceptor (CD86) and a neuroreceptor (beta2AR) converge to regulate the IgG1 re
11 re concurrent declines in caudate/putamen D2 neuroreceptor binding and tissue volume.
12  cerebral blood flow, glucose metabolism and neuroreceptor binding are influenced by partial-volume a
13 etry (AMS) allowed the use of [(14)C]TETS in neuroreceptor binding studies with rat brain membranes i
14  noninvasive measures of neurophysiology and neuroreceptor binding, are powerful and sensitive tools
15                          However, subsequent neuroreceptor changes including monoamine deficits compl
16 g was observed with 10 nM GE-179 at 60 other neuroreceptors, channels, or transporters.
17 to investigate the neuropharmacokinetics and neuroreceptor correlate, at least at u-OR, of the acute
18 of psychedelics interacting with several key neuroreceptors distributed across the brain.
19 ted two and three UAAs simultaneously into a neuroreceptor expressed in vivo.
20 he elucidation of the broad diversity of the neuroreceptor families.
21                                              Neuroreceptor imaging in the nonhuman primate (NHP) is v
22 f kinetic analysis of radioligand binding to neuroreceptors in brain in vivo, here applied to noradre
23 ytryptamine-2 or 5-HT2A) and dopamine-2 (D2) neuroreceptors in subjects being treated with typical or
24 -gated ion channels that are the predominant neuroreceptors in the mammalian brain.
25 it is essential for clustering of inhibitory neuroreceptors in the postsynaptic membrane.
26 hetic and non-anesthetic effects mediated by neuroreceptors, ion channels, and the mitochondrial elec
27                 The brain's major inhibitory neuroreceptor is the ligand-gated ion channel gamma-amin
28  inferred that the approach to deliver small neuroreceptor ligands across the BBB by transport peptid
29                        Neonicotinoids act as neuroreceptor modulators, and some studies have reported
30 d not appear to bind significantly to common neuroreceptors or transporter sites.
31 ronal activation using Fos and neurochemical/neuroreceptor profiles on brain areas involved in these
32 e introduced and commonly used PET and SPECT neuroreceptor quantification models are discussed.
33                Positron emission tomographic neuroreceptor studies are needed to determine whether po
34 esponse and inflammation, alongside specific neuroreceptor systems, in shared and distinct rCBF pheno
35 e A receptor (GABAA-R) is a major inhibitory neuroreceptor that is activated by the binding of GABA.
36 ludes the sinus node or AV node or important neuroreceptors; whether many small arteries are occluded